Farmalider S.A. — Sponsor Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

1 Recruiting

9 Completed trials

3 Countries active

6 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I (Other)

Phase III: 3 Phase II: 1 Phase I (Other): 6

100%

9 of 9 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

MONTELUKAST 2 TRAMADOL HYDROCHLORIDE 2 TRAMADOL HYDROCHLORIDE, IBUPROFEN 2 IBUPROFEN ARGININE 1 SODIUM CHLORIDE 1

All trials

10 total

RANDOMISED, MULTICENTRE, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF MONTELUKAST VS. PLACEBO IN PATIENTS WITH EROSIVE… Recruiting

2025-521802-17-00 Phase III 3 countries MONTELUKAST
Pilot, randomized, crossover, comparative bioavailability study of two tadalafil formulations (oral suspension and film-coated tablets) afte… Ended

2026-525930-47-00 Phase I (Other) 1 country
OPEN-LABEL PALATABILITY STUDY OF A NOVEL ORODISPERSIBLE PARACETAMOL/IBUPROFEN FORMULATION AFTER A SINGLE ORAL ADMINISTRATION IN HEALTHY SUBJ… Ended

2025-524274-41-00 Phase I (Other) 1 country
RANDOMIZED, CROSSOVER, TWO-PERIOD, COMPARATIVE BIOAVAILABILITY STUDY OF TWO IBUPROFEN FORMULATIONS, AFTER A SINGLE ORAL DOSE OF 400 MG IN SO… Ended

2025-520852-27-00 Phase I (Other) 1 country
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single do… Ended

2024-519661-22-00 Phase I (Other) 1 country
Randomized, crossover, two-period, comparative bioavailability study of two ibuprofen (arginate) formulations, administered as solutions in … Ended

2024-514478-37-00 Phase I (Other) 1 country
Randomized, crossover, two-period, two-treatment, comparative bioavailability study of ibuprofen (arginine) granules for oral solution, deve… Ended

2023-509219-97-00 Phase I (Other) 1 country
Phase III, double-blind, randomised, placebo- and active treatment-controlled clinical trial to evaluate the analgesic efficacy and safety o… Ended

2023-505687-11-00 Phase III 1 country SODIUM CHLORIDE; TRAMADOL HYDROCHLORIDE; TRAMADOL HYDROCHLORIDE, IBUPROFEN
A randomized, multi-centre, double-blind, phase II clinical trial of dose finding of Montelukast in patients with erosive osteoarthritis of … Ended

2023-506137-30-00 Phase II 1 country MONTELUKAST
Randomised, double-blind, placebo-controlled, active-treatment clinical trial to assess the analgesic efficacy and safety of an oral combina… Ended

2024-517807-35-00 Phase III 1 country IBUPROFEN ARGININE; TRAMADOL HYDROCHLORIDE; TRAMADOL HYDROCHLORIDE, IBUPROFEN

Showing 1–10 of 10 trials

← All sponsors A–Z